Explore how irinogenetics uses genetic markers to personalize cancer treatment with irinotecan, improving efficacy while reducing side effects.
A groundbreaking new type of cell death called cuproptosis is revolutionizing our understanding of cancer treatment and opening doors to personalized therapies for colon cancer patients.